Point72 Asset Management’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.6M | Buy |
5,966,664
+3,099,567
| +108% | +$25.2M | 0.1% | 234 |
|
|
2025
Q1 | $22.5M | Buy |
2,867,097
+870,818
| +44% | +$6.84M | 0.05% | 362 |
|
|
2024
Q4 | $29.7M | Sell |
1,996,279
-440,794
| -18% | -$6.56M | 0.07% | 311 |
|
|
2024
Q3 | $37.3M | Buy |
2,437,073
+603,222
| +33% | +$9.22M | 0.09% | 232 |
|
|
2024
Q2 | $27.9M | Sell |
1,833,851
-81,081
| -4% | -$1.23M | 0.07% | 297 |
|
|
2024
Q1 | $36.2M | Buy |
1,914,932
+1,146,182
| +149% | +$21.6M | 0.09% | 262 |
|
|
2023
Q4 | $14.7M | Buy |
768,750
+764,293
| +17,148% | +$14.6M | 0.04% | 472 |
|
|
2023
Q3 | $80K | Sell |
4,457
-705,184
| -99% | -$12.7M | ﹤0.01% | 1353 |
|
|
2023
Q2 | $14.4M | Buy |
+709,641
| New | +$14.4M | 0.04% | 433 |
|
|
2023
Q1 | – | Sell |
-425,301
| Closed | -$8.8M | – | 1937 |
|
|
2022
Q4 | $8.8M | Buy |
425,301
+367,467
| +635% | +$7.6M | 0.03% | 530 |
|
|
2022
Q3 | $1.51M | Buy |
+57,834
| New | +$1.51M | 0.01% | 801 |
|
|
2021
Q2 | – | Sell |
-62,926
| Closed | -$1.77M | – | 1073 |
|
|
2021
Q1 | $1.77M | Buy |
+62,926
| New | +$1.77M | 0.01% | 694 |
|
|
2020
Q4 | – | Sell |
-194,001
| Closed | -$3.33M | – | 1035 |
|
|
2020
Q3 | $3.33M | Buy |
+194,001
| New | +$3.33M | 0.02% | 589 |
|